DREAM5: An open-label, randomized, cross-over study to evaluate the safety and efficacy of day and night closed-loop control by comparing the MD-Logic automated insulin delivery system to sensor augmented pump therapy in patients with type 1 diabetes at home

  • Torben Biester
  • , Judith Nir
  • , Kerstin Remus
  • , Alon Farfel
  • , Ido Muller
  • , Sarah Biester
  • , Eran Atlas
  • , Klemen Dovc
  • , Nataša Bratina
  • , Olga Kordonouri
  • , Tadej Battelino
  • , Moshe Philip
  • , Thomas Danne
  • , Revital Nimri*
    • *Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

28 Scopus citations

Fingerprint

Dive into the research topics of 'DREAM5: An open-label, randomized, cross-over study to evaluate the safety and efficacy of day and night closed-loop control by comparing the MD-Logic automated insulin delivery system to sensor augmented pump therapy in patients with type 1 diabetes at home'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

Neuroscience

Food Science